| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.07 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |